Bank of Montreal Can Has $1.63 Million Position in Chemed Co. (NYSE:CHE)

Bank of Montreal Can trimmed its stake in shares of Chemed Co. (NYSE:CHE) by 43.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,082 shares of the company’s stock after selling 2,391 shares during the quarter. Bank of Montreal Can’s holdings in Chemed were worth $1,633,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CHE. UMB Bank n.a. increased its holdings in shares of Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after buying an additional 39 shares in the last quarter. Atala Financial Inc bought a new stake in Chemed during the 4th quarter worth $29,000. CBIZ Investment Advisory Services LLC increased its holdings in Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after purchasing an additional 22 shares in the last quarter. Trust Co. of Vermont bought a new position in Chemed in the fourth quarter valued at about $34,000. Finally, Tortoise Investment Management LLC boosted its stake in shares of Chemed by 77.3% during the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after purchasing an additional 34 shares in the last quarter. Institutional investors own 95.85% of the company’s stock.

Insider Buying and Selling

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the sale, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 3.32% of the stock is owned by company insiders.

Chemed Stock Performance

Shares of CHE opened at $580.52 on Friday. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $623.61. The business’s 50 day moving average price is $585.78 and its two-hundred day moving average price is $567.83. The firm has a market cap of $8.48 billion, a PE ratio of 29.33, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49.

Chemed Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date of this dividend was Monday, February 24th. Chemed’s dividend payout ratio (DPR) is currently 10.05%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on CHE shares. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada boosted their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.